Role of selegiline in combination therapy of Parkinson's disease.
Myllylä
V V
VV
Department of Neurology, University of Oulu, Finland.
Sotaniemi
K
K
Mäki-Ikola
O
O
Rinne
U K
UK
Heinonen
E H
EH
D000978:Antiparkinson Agents / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D012642:Selegiline; D007980:Levodopa